BioCentury | Feb 25, 2019
Company News

Management tracks: Viriom, Matinas, Atreca

...of Armo BioSciences Inc., which Eli Lilly and Co. (NYSE:LLY) acquired last year. Diagnostics company Cellanyx LLC...
BioCentury | Jul 20, 2015
Clinical News

Live tumor cell diagnostic: Pilot trial data

...vs. G7 lesions. Data were presented at the American Urological Association meeting in New Orleans. Cellanyx Diagnostics...
Items per page:
1 - 2 of 2
BioCentury | Feb 25, 2019
Company News

Management tracks: Viriom, Matinas, Atreca

...of Armo BioSciences Inc., which Eli Lilly and Co. (NYSE:LLY) acquired last year. Diagnostics company Cellanyx LLC...
BioCentury | Jul 20, 2015
Clinical News

Live tumor cell diagnostic: Pilot trial data

...vs. G7 lesions. Data were presented at the American Urological Association meeting in New Orleans. Cellanyx Diagnostics...
Items per page:
1 - 2 of 2